Drug hypersensitivity: Mechanisms and opportunities of laboratory diagnostics ; Лекарственная гиперчувствительность. Механизмы формирования и возможности лабораторной диагностики

SPb RAACI

2022

Medical Immunology (E-Journal) / Медицинская иммунология

application/pdf

https://www.mimmun.ru/mimmun/article/view/2396/1518; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2396/8787; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2396/8788; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2396/8789; Бычкова Н.В. Активация базофилов: теоретические аспекты и применение в диагностике аллергических заболеваний // Медицинская иммунология, 2021. Т. 23, № 3. С. 481-494. doi:10.15789/1563-0625-BAT-2174.; Симбирцев А.С. Цитокины в иммунопатогенезе аллергии // Российский медицинский журнал «Медицинское обозрение», 2021. № 1. С. 32-37.; Федеральные клинические рекомендации по диагностике и лечению лекарственной аллергии // Клинические рекомендации. Аллергология и клиническая иммунология / Под ред. Хаитова Р.М., Ильиной Н.И. М.: ГЭОТАР-Медиа, 2019. С. 190-213.; Aberer W., Bircher A., Romano A., Blanca M., Campi P., Fernandez J., Brockow K., Pichler W.J., Demoly P.; European Network for Drug Allergy (ENDA); EAACI interest group on drug hypersensitivity. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy, 2003, Vol. 58, no. 9, pp. 854-863.; Ansotegui I.J., Melioli G., Canonica G.W., Caraballo L., Villa E., Ebisawa M., Passalacqua G., Savi E., Ebo D., Gómez R.M., Luengo Sánchez O., Oppenheimer J.J., Jensen-Jarolim E., Fischer D.A., Haahtela T., Antila M., Bousquet J.J., Cardona V., Chiang W.C., Demoly P.M., DuBuske L.M., Ferrer Puga M., Gerth van Wijk R., González Díaz S.N., Gonzalez-Estrada A., Jares E., Kalpaklioğlu A.F., Kase Tanno L., Kowalski M.L., Ledford D.K., Monge Ortega O.P., Morais Almeida M., Pfaar O., Poulsen L.K., Pawankar R., Renz H.E., Romano A.G., Rosário Filho N.A., Rosenwasser L., Sánchez Borges M.A., Scala E., Senna G.E., Sisul J.C., Tang M.L.K., Thong B.Y., Valenta R., Wood R.A., Zuberbier T. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper. World Allergy Organ J., 2020, Vol. 13, no. 2, 100080. doi:10.1016/j.waojou.2019.100080.; Aydogan M., Yologlu N., Gacar G., Uyan Z.S., Eser I., Karaoz E. Successful rapid rituximab desensitization in an adolescent patient with nephrotic syndrome: Increase in number of Treg cells after desensitization. J. Allergy Clin. Immunol., 2013, Vol. 132, no. 2, pp. 478-480.; Barbaud A. Skin testing and patch testing in non-IgE-mediated drug allergy. Curr. Allergy Asthma Rep., 2014, Vol. 14, no. 6, 442. doi:10.1007/s11882-014-0442-8.; Beeler A., Pichler W.J. In vitro tests of T-cell-mediated drug hypersensitivity. Drug hypersensensivity. Basel, Karger, 2007, pp. 380-390.; Berroa F., Lafuente A., Javaloyes G., Ferrer M., Moncada R., Goikoetxea M.J., Urbain C.M., Sanz M.L., Gastaminza G. The usefulness of plasma histamine and different tryptase cut-off points in the diagnosis of peranaesthetic hypersensitivity reactions. Clin. Exp. Allergy, 2014, Vol. 44, no. 2, pp. 270-277.; Beyaz Ş., Akdeniz N., Yılmaz A., Demir S., Öztop N., Çolakoğlu B., Büyüköztürk S., Deniz G., Gelincik A. Diagnostic workup including CD203c-based basophil activation test in immediate hypersensitivity due to metronidazole and ornidazole and evaluation of cross-reactivity in between. Allergy, 2021, Vol. 76, no. 3, pp. 842-852.; Blumenthal K.G., Li Y., Acker W.W., Chang Y., Banerji A., Ghaznavi S., Camargo C.A. Jr., Zhou L. Multiple drug intolerance syndrome and multiple drug allergy syndrome: Epidemiology and associations with anxiety and depression. Allergy, 2018, Vol. 73, no. 10, pp. 2012-2023.; Boonpiyathad T., Sözener Z.C., Akdis M., Akdis C.A. The role of Treg cell subsets in allergic disease. Asian Pac. J. Allergy Immunol., 2020, Vol. 38, no. 3, pp. 139-149.; Branchett W., Lloyd C. Regulatory cytokine function in the respiratory tract. Mucosal Immunol., 2019, Vol. 12, no. 3, pp. 589-600.; Brockow K., Garvey L.H., Aberer W., Atanaskovic-Markovic M., Barbaud A., Bilo M.B., Bircher A., Blanca M., Bonadonna B., Campi P., Castro E., Cernadas J.R., Chiriac A.M., Demoly P., Grosber M., Gooi J., Lombardo C., Mertes P.M., Mosbech H., Nasser S., Pagani M., Ring J., Romano A., Scherer K., Schnyder B., Testi S., Torres M., Trautmann A., Terreehorst I; ENDA/EAACI Drug Allergy Interest Group. Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy, 2013, Vol. 68, no. 6, pp. 702-712.; Broyles A.D., Banerji A., Castells M. Practical guidance for the evaluation and management of drug hypersensitivity: general concepts. J. Allergy Clin. Immunol. Pract., 2020, Vol. 8, no. 9S, pp. S3-S15.; Campos L., Galvão V.R., Kalil J., Castells M., Giavina-Bianchi P. BAT in the diagnosis of drug allergy: a novel tool in clinical daily practice? Curr. Allergy Asthma Rep., 2019, Vol. 19, no. 4, 20. doi:10.1007/s11882-019-0852-8.; Chen C.B., Abe R., Pan R.Y., Wang C.W., Hung S.I., Tsai Y.G., Chung W.H. An updated review of the molecular mechanisms in drug hypersensitivity. J. Immunol. Res., 2018, Vol. 2018, 6431694. doi:10.1155/2018/6431694; Choi J.H., Kim M.A., Park H.S. An update on the pathogenesis of the upper airways in aspirin-exacerbated respiratory disease. Curr. Opin. Allergy Clin. Immunol., 2014, Vol. 14, no. 1, pp. 1-6.; Chung W.H., Hung S.I., Hong H.S., Hsih M.S., Yang L.C., Ho H.C., Wu J.Y., Chen Y.T. Medical genetics: a marker for Stevens-Johnson syndrome. Nature, 2004, Vol. 428, no. 6982, 486. doi:10.1038/428486a.; Coombs P.R., Gell P.G. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell, R.R., Ed., Clinical Aspects of Immunology, Oxford University Press, 1968, Oxford, pp. 575-596.; Costa Carvalho J.L., de Brito A.A., de Oliveira A.P., de Castro Faria Neto H.C., Pereira T.M., de Carvalho R.A., Anatriello E., Aimbire F. The chemokines secretion and the oxidative stress are targets of low-level laser therapy in allergic lung inflammation. J. Biophotonics, 2016, Vol. 9, no. 11-12, pp. 1208-1221.; Daubner B., Groux-Keller M., Hausmann O.V., Kawabata T., Naisbitt D.J., Park B.K., Wendland T., Lerch M., Pichler W.J. Multiple drug hypersensitivity: normal Treg cell function but enhanced in vivo activation of drugspecific T cells. Allergy, 2012, Vol. 67, no. 1, pp. 58-66.; de Las Vecillas Sánchez L., Alenazy L.A., Garcia-Neuer M., Castells M.C. Drug hypersensitivity and desensitizations: mechanisms and new approaches. Int. J. Mol. Sci., 2017, Vol. 18, no. 6, 1316. doi:10.3390/ijms18061316.; Demoly P., Adkinson N.F., Brockow K., Castells M., Chiriac A.M., Greenberger P.A., Khan D.A., Lang D.M., Park H.S., Pichler W., Sanchez-Borges M., Shiohara T., Thong B.Y. International Consensus on drug allergy. Allergy, 2014, Vol. 69, no. 4, pp. 420-437.; Dewachter P., Chollet-Martin S., Mouton-Faivre C., de Chaisemartin L., Nicaise-Roland P. Comparison of basophil activation test and skin testing performances in NMBA allergy. J. Allergy Clin. Immunol. Pract., 2018, Vol. 6, no. 5, pp. 1681-1689.; Edwards I.R., Aronson J.K. Adverse drug reactions: definitions, diagnosis, and management. Lancet, 2000, Vol. 356, no. 9237, pp. 1255-1259.; Elsheikh M.S., Mohamed N.H., Alsharkawy A.A.A. Improvement of asthma control after laser acupuncture and its impact on exhaled 8-isoprostane as an oxidative biomarker in chronic bronchial asthma. Respir. Med., 2019, Vol. 156, pp. 15-19.; Fernandez T.D., Mayorga C., Salas M., Barrionuevo E., Posadas T., Ariza A., Laguna J.J., Moreno E., Torres M.J., Doña I., Montañez M.I. Evolution of diagnostic approaches in betalactam hypersensitivity. Expert Rev. Clin. Pharmacol., 2017, Vol. 10, no. 6, pp. 671-683.; Hemmings O., Kwok M., McKendry R., Santos A.F. Basophil activation test: old and new applications in allergy. Curr. Allergy Asthma Rep., 2018, Vol. 18, no. 12, 77. doi:10.1007/s11882-018-0831-5. Erratum in: Curr. Allergy Asthma Rep., 2019, Vol. 19, no. 12, 58. doi:10.1007/s11882-018-0831-5.; Hoffmann H.J., Santos A.F., Mayorga C., Nopp A., Eberlein B., Ferrer M., Rouzaire P., Ebo D.G., Sabato V., Sanz M.L., Pecaric-Petkovic T., Patil S.U., Hausmann O.V., Shreffler W.G., Korosec P., Knol E.F. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy, 2015, Vol. 70, no. 11, pp. 1393-1405.; Horiuchi T., Yokohama A., Orihara M., Tomita Y., Tomioka A., Yoshida N., Takahashi K., Saito S., Takazawa T. Usefulness of basophil activation tests for diagnosis of sugammadex-induced anaphylaxis. Anesth. Analg., 2018, Vol. 126, no. 5, pp. 1509-1516.; Huang F., Yin J.N., Wang H.B., Liu S.Y., Li Y.N. Association of imbalance of effector T cells and regulatory cells with the severity of asthma and allergic rhinitis in children. Allergy Asthma Proc., 2017, Vol. 38, no. 6, pp. 70-77.; Hung S.I., Chung W.H., Liu Z.S., Chen C.H., Hsih M.S., Hui R.C., Chu C.Y., Chen Y.T. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics, 2010, Vol. 11, no. 3, pp. 349-356.; Johansson S.G., Hourihane J.O., Bousquet J., Bruijnzeel-Koomen C., Dreborg S., Haahtela T., Kowalski M.L., Mygind N., Ring J., van Cauwenberge P., van Hage-Hamsten M., Wüthrich B. EAACI (the European Academy of Allergology and Cinical Immunology) nomenclature task force. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy, 2001, Vol. 56, no. 9, pp. 813-824.; Kano Y., Hirahara K., Mitsuyama Y., Takahashi R., Shiohara T. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy, 2007, Vol. 62, no. 12, pp. 1439-1444.; Laguna J.J., Bogas G., Salas M., Mayorga C., Dionicio J., Gonzalez-Mendiola R., Ariza A., FernándezSantamaría R., Olazabal I., Doña I., Fernandez T.D., Torres M.J. The basophil activation test can be of value for diagnosing immediate allergic reactions to omeprazole. J. Allergy Clin. Immunol. Pract., 2018, Vol. 6, no. 5, pp. 1628-1636.e2.; Landsteiner K. Über heterogenetisches Hapten und Antigen. Biochemische Zeitschrift, Band, 1921, Vol. 119, pp. 294-306.; Lochmatter P., Beeler A., Kawabata T.T., Gerber B.O., Pichler W.J. Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-gamma in patients with delayed-type drug hypersensitivity. Allergy, 2009, Vol. 64, no. 9, pp. 1269-1278.; Luque I., Leyva L., José Torres M., Rosal M., Mayorga C., Segura J.M., Blanca M., Juárez C. In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions. Allergy, 2001, Vol. 56, no. 7, pp. 611-618.; Marraccini P., Pignatti P., Alcama A.D.A., Salimbeni R., Consonni D. Basophil activation test application in drug hypersensitivity diagnosis: an empirical approach. Int. Arch. Allergy Immunol., 2018, Vol. 177, no. 2, pp. 160-166.; Matsuda M., Terada T., Tsujimoto N., Morie Y., Ishida T., Takahashi H., Hamaguchi J., Tabuchi Y., Doi K., Noro K., Kikuoka Y., Omura S., Yoshida T., Ayani Y., Suzuki M., Ichihara T., Inaka Y., Inui T., Kawata R., Nabe T. Regulatory T and B cells in peripheral blood of subcutaneous immunotherapy-treated Japanese cedar pollinosis patients. Immunotherapy, 2019, Vol. 11, no. 6, pp. 473-482.; Mayorga C., Celik G., Rouzaire P., Whitaker P., Bonadonna P., Rodrigues-Cernadas J., Vultaggio A., Brockow K., Caubet J.C., Makowska J., Nakonechna A., Romano A., Montañez M.I., Laguna J.J., Zanoni G., Gueant J.L., Oude Elberink H., Fernandez J., Viel S., Demoly P., Torres M.J. In vitro tests for Drug Allergy Task Force of EAACI Drug Interest Group. In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy, 2016, Vol. 71, no. 8, pp. 1103-1134.; Mayorga C., Sanz M.L., Gamboa P.M., García B.E., Caballero M.T., García J.M., Labrador M., Lahoz C., Longo Areso N., López Hoyos M., Martínez Quesada J., Monteseirín F.J;. Immunology Committee of the Spanish Society of Allergology and Clinical Immunology of the SEAIC. In vitro diagnosis of immediate allergic reactions to drugs: an update. J. Investig. Allergol. Clin. Immunol., 2010, Vol. 20, no. 2, pp. 103-109.; McNeil B.D., Pundir P., Meeker S., Han L., Undem B.J., Kulka M., Dong X. Identification of a mast-cellspecific receptor crucial for pseudo-allergic drug reactions. Nature, 2015, Vol. 519, no. 7542, pp. 237-241.; Muraro A., Lemanske R.F. Jr., Castells M., Torres M.J., Khan D., Simon H.U., Bindslev-Jensen C., Burks W., Poulsen L.K,, Sampson H.A., Worm M., Nadeau K.C. Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology. Allergy, 2017, Vol. 72, no. 7, pp. 1006-1021.; Nakashima C., Otsuka A., Kabashima K. Recent advancement in the mechanism of basophil activation. J. Dermatol. Sci., 2018, Vol. 91, no. 1, pp. 3-8.; Norcross M.A., Luo S., Lu L., Boyne M.T., Gomarteli M., Rennels A.D., Woodcock J., Margulies D.H., McMurtrey C., Vernon S., Hildebrand W.H., Buchli R. Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity. AIDS, 2012, Vol. 26, no. 11, pp. F21-29.; Ornelas C., Caiado J., Campos Melo A., Pereira Barbosa M., Castells M.C., Pereira Dos Santos M.C. The contribution of the basophil activation test to the diagnosis of hypersensitivity reactions to oxaliplatin. Int. Arch. Allergy Immunol., 2018, Vol. 177, no. 3, pp. 274-280.; Palomares O., Akdis M., Martín-Fontecha M., Akdis C.A. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. Immunol. Rev., 2017, Vol. 278, no. 1, pp. 219-236.; Park K.H., Lee J., Beom S.H., Shin S.J., Ahn J.B., Kim S.R., Lee J.H., Park J.W. Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection. World Allergy Organ J., 2021, Vol. 14, no. 7, 100553. doi:10.1016/j.waojou.2021.100553.; Picard M., Castells M.C. Re-visiting hypersensitivity reactions to taxanes: a comprehensive review. Clin. Rev. Allergy Immunol., 2015, Vol. 49, no. 2, pp. 177-191.; Pichler W.J., Beeler A., Keller M., Lerch M., Posadas S., Schmid D., Spanou Z., Zawodniak A., Gerber B. Pharmacological interaction of drugs with immune receptors: the p-i concept. Allergol. Int., 2006, Vol. 55, no. 1, pp. 17-25.; Pichler W.J., Srinoulprasert Y., Yun J., Hausmann O. Multiple drug hypersensitivity. Int. Arch. Allergy Immunol., 2017, Vol. 172, no. 3, pp. 129-138.; Porebski G., Gschwend-Zawodniak A., Pichler W.J. In vitro diagnosis of T cell-mediated drug allergy. Clin. Exp. Allergy, 2011, Vol. 41, no. 4, pp. 461-470.; Pumar M., Varese N., Hew M., O’Hehir R.E., Zubrinich C. Trimethoprim anaphylaxis confirmed by a novel basophil activation test. Ann. Allergy Asthma Immunol., 2021, Vol. 126, no. 6, pp. 722-723.; Renaudin J.M., Beaudouin E., Ponvert C., Demoly P., Moneret-Vautrin D.A. Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010. Allergy, 2013, Vol. 68, no. 7, pp. 29-37.; Sadleir P.H., Clarke R.C., Bunning D.L., Platt P.R. Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011. Br. J. Anaesth., 2013, Vol. 110, no. 6, pp. 981-987.; Sala-Cunill A., Cardona V., Labrador-Horrillo M., Luengo O., Esteso O., Garriga T., Vicario M., Guilarte M. Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. Int. Arch. Allergy Immunol., 2013 Vol. 160, no. 2, pp. 192-199.; Salas M., Gomez F., Fernandez T.D., Doña I., Aranda A., Ariza A., Blanca-López N., Mayorga C., Blanca M., Torres M.J. Diagnosis of immediate hypersensitivity reactions to radiocontrast media. Allergy, 2013, Vol. 68, no. 9, pp. 1203-1206.; Sheen C.H., Schleimer R.P., Kulka M. Codeine induces human mast cell chemokine and cytokine production: involvement of G-protein activation. Allergy, 2007, Vol. 62, no. 5532-5538.; Silva V.R., Marcondes P., Silva M., Villaverde A.B., Castro-Faria-Neto H.C., Vieira R.P., Aimbire F., de Oliveira A.P. Low-level laser therapy inhibits bronchoconstriction, Th2 inflammation and airway remodeling in allergic asthma. Respir. Physiol. Neurobiol., 2014, Vol. 194, pp. 37-48.; Sompornrattanaphan M., Kanistanon D., Srinoulprasert Y., Udnaen S., Jongjarearnprasert K., Wongsa C., Thongngarm T. Ortho-phthalaldehyde-induced anaphylaxis after cystoscopy: confirmation by the basophil activation test. J. Investig. Allergol. Clin. Immunol., 2020, Vol. 30, no. 5, pp. 365-367.; Szebeni J., Alving C.R., Savay S., Barenholz Y., Priev A., Danino D., Talmon Y. Formation of complementactivating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions. Int. Immunopharmacol., 2001, Vol. 1, no. 4, pp. 721-735.; Thinnes A., Merk H.F., Wurpts G., Röseler S., Lehmann S., Tenbrock K., Baron J.M., Balakirski G. Individual risk assessment in the diagnosis of immediate type drug hypersensitivity reactions to betalactam and non-betalactam antibiotics using basophil activation test: a single center experience. Cutan. Ocul. Toxicol., 2018, Vol. 37, no. 4, pp. 309-318.; Watkins S., Pichler W.J. Sulfamethoxazole induces a switch mechanism in T cell receptors containing TCRVβ20-1, altering pHLA recognition. PLoS One, 2013, Vol. 8, no. 10, e76211. doi:10.1371/journal.pone.0076211.; Wedi B., Gehring M., Kapp A. The pseudoallergen receptor MRGPRX2 on peripheral blood basophils and eosinophils: Expression and function. Allergy, 2020, Vol. 75, no. 9, pp. 2229-2242.; White K.D., Chung W.H., Hung S.I., Mallal S., Phillips E.J. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response. J. Allergy Clin. Immunol., 2015, Vol. 136, no. 2, pp. 219-235.; Yao Y., Chen C.L., Yu D., Liu Z. Roles of follicular helper and regulatory T cells in allergic diseases and allergen immunotherapy. Allergy, 2021, Vol. 76, no. 2, pp. 456-470.; Yun J., Marcaida M.J., Eriksson K.K., Jamin H., Fontana S., Pichler W.J., Yerly D. Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01. J. Immunol., 2014, Vol. 192, no. 7, pp. 2984-2993.; Zhang B., Li Q., Shi C., Zhang X. Drug-induced pseudoallergy: a review of the causes and mechanisms. Pharmacology, 2018, Vol. 101, no. 1-2, pp. 104-110.; https://www.mimmun.ru/mimmun/article/view/2396

10.15789/1563-0625-DHM-2396

https://www.mimmun.ru/mimmun/article/view/2396
https://doi.org/10.15789/1563-0625-DHM-2396

Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). ; Авторы, публикующие в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License, которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в этом журнале.Авторы сохраняют право заключать отдельные контрактные договорённости, касающиеся не-эксклюзивного распространения версии работы в опубликованном здесь виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию в этом журнале.Авторы имеют право размещать их работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу (См. The Effect of Open Access).

edsbas.4919B396